Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa March 27, 2024 Read More »
Vector Pharma FZCO Announce Exclusive Distribution Agreement with Ascendis Pharma A/S for Skytrofa (lonapegsomatropin) and Yorvipath (palopegteriparatide) in Gulf Cooperation Council Countries January 8, 2024 Read More »
World Orphan Drug Alliance Announces Agreement with Theratechnologies for the Distribution of EGRIFTA SV January 5, 2023 Read More »